相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Emerging roles for the relaxin/RXFP1 system in cancer therapy
Thatchawan Thanasupawat et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Next-generation characterization of the Cancer Cell Line Encyclopedia
Mahmoud Ghandi et al.
NATURE (2019)
Follicle-Stimulating Hormone Is an Autocrine Regulator of the Ovarian Cancer Metastatic Niche Through Notch Signaling
Sakshi Gera et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2019)
STAT3/PIAS3 Levels Serve as Early Signature Genes in the Development of High-Grade Serous Carcinoma from the Fallopian Tube
Uksha Saini et al.
CANCER RESEARCH (2018)
Lysophospholipid Signaling in the Epithelial Ovarian Cancer Tumor Microenvironment
Yan Xu
CANCERS (2018)
IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis
Landon Browning et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Serum relaxin as a diagnostic and prognostic marker in patients with epithelial ovarian cancer
Xiaojing Guo et al.
CANCER BIOMARKERS (2018)
The Role of Relaxin in Normal and Abnormal Uterine Function During the Menstrual Cycle and Early Pregnancy
Sarah A. Marshall et al.
REPRODUCTIVE SCIENCES (2017)
Notch and its oncogenic activity in human malignancies
Marlena Brzozowa-Zasada et al.
EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA (2017)
Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells
Robin M. Meyers et al.
NATURE GENETICS (2017)
Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High- Grade Serous Ovarian Cancer
Mauricio Medrano et al.
CELL REPORTS (2017)
Fibroblast growth factor-mediated crosstalk in cancer etiology and treatment
N. S. Clayton et al.
DEVELOPMENTAL DYNAMICS (2017)
Tumor-Host Cell Interactions in Ovarian Cancer: Pathways to Therapy Failure
Elke Pogge von Strandmann et al.
TRENDS IN CANCER (2017)
G protein-coupled receptors as promising cancer targets
Ying Liu et al.
CANCER LETTERS (2016)
Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer
Soochi Kim et al.
CANCER SCIENCE (2016)
The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins
Andrew D. Rouillard et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2016)
Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium
Laura H. Rodgers et al.
ONCOTARGET (2016)
Genomic/Epigenomic Alterations in Ovarian Carcinoma: Translational Insight into Clinical Practice
Anliang Dong et al.
JOURNAL OF CANCER (2016)
Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-alpha and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer
Nonna Kolomeyevskaya et al.
GYNECOLOGIC ONCOLOGY (2015)
International Union of Basic and Clinical Pharmacology. XCV. Recent Advances in the Understanding of the Pharmacology and Biological Roles of Relaxin Family Peptide Receptors 1-4, the Receptors for Relaxin Family Peptides
Michelle L. Halls et al.
PHARMACOLOGICAL REVIEWS (2015)
Relaxin receptor antagonist AT-001 synergizes with docetaxel in androgen-independent prostate xenografts
Anton Neschadim et al.
ENDOCRINE-RELATED CANCER (2014)
Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes
Corine M. Beaufort et al.
PLOS ONE (2014)
Notch signaling in serous ovarian cancer
Jolijn W. Groeneweg et al.
JOURNAL OF OVARIAN RESEARCH (2014)
The versatile functions of Sox9 in development, stem cells, and human diseases
Alice Jo et al.
GENES & DISEASES (2014)
Cytotoxicity enhancement in MDA-MB-231 cells by the combination treatment of tetrahydropalmatine and berberine derived from Corydalis yanhusuo W.T. Wang
Yan Zhao et al.
JOURNAL OF INTERCULTURAL ETHNOPHARMACOLOGY (2014)
RELAXIN FAMILY PEPTIDES AND THEIR RECEPTORS
R. A. D. Bathgate et al.
PHYSIOLOGICAL REVIEWS (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Evaluating cell lines as tumour models by comparison of genomic profiles
Silvia Domcke et al.
NATURE COMMUNICATIONS (2013)
Chimeric RXFP1 and RXFP2 Receptors Highlight the Similar Mechanism of Activation Utilizing Their N-Terminal Low-Density Lipoprotein Class A Modules
Shoni Bruell et al.
Frontiers in Endocrinology (2013)
Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research
Nuzhat Ahmed et al.
FRONTIERS IN ONCOLOGY (2013)
The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer
Morgan O'Hayre et al.
NATURE REVIEWS CANCER (2013)
Oncogenicity of the Developmental Transcription Factor Sox9
Ander Matheu et al.
CANCER RESEARCH (2012)
Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells
Yue Wang et al.
CYTOKINE (2012)
Inflammation and ovarian cancer
Antonio Maccio et al.
CYTOKINE (2012)
Relaxin induces matrix-metalloproteinases-9 and-13 via RXFP1: Induction of MMP-9 involves the PI3K, ERK, Akt and PKC-ζ pathways
Nisar Ahmad et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Relaxin augments the inflammatory IL6 response in the choriodecidua
J. S. Horton et al.
PLACENTA (2012)
Essential Gene Profiles in Breast, Pancreatic, and Ovarian Cancer Cells
Richard Marcotte et al.
CANCER DISCOVERY (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Relaxin Modulates Proinflammatory Cytokine Secretion from Human Decidual Macrophages
J. S. Horton et al.
BIOLOGY OF REPRODUCTION (2011)
Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
Jermaine Coward et al.
CLINICAL CANCER RESEARCH (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Ovarian Cancer Development and Metastasis
Ernst Langyel
AMERICAN JOURNAL OF PATHOLOGY (2010)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Beyond chemotherapy: targeted therapies in ovarian cancer
Timothy A. Yap et al.
NATURE REVIEWS CANCER (2009)
The Human Protein Atlas - a tool for pathology
F. Ponten et al.
JOURNAL OF PATHOLOGY (2008)
Developmental expression and gene regulation of insulin-like 3 receptor RXFP2 in mouse male reproductive organs
Shu Feng et al.
BIOLOGY OF REPRODUCTION (2007)
Relaxin Family Peptide Receptors - former orphans reunite with their parent ligands to activate multiple signalling pathways
M. L. Halls et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Y. Lee et al.
JOURNAL OF PATHOLOGY (2007)
Autocrine activation of PDGFRα promotes the progression of ovarian cancer
D Matei et al.
ONCOGENE (2006)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2
S Sudo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)